Onderneming Exalenz Bioscience Ltd
Aandelen
EXEN
IL0011048688
Medische apparatuur, benodigdheden & distributie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- ILa | -.--% | +1,39% | +107,88% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01-10-10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29-01-19 |
Eitan Blank
COO | Chief Operating Officer | 53 | 01-01-07 |
Ofer Schlesinger
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-07-14 |
Ilan Ben Oren
CTO | Chief Tech/Sci/R&D Officer | 59 | 11-04-06 |
Didier Samuel
PRN | Corporate Officer/Principal | - | - |
Ari Soae
PRN | Corporate Officer/Principal | 46 | 01-01-06 |
Ilan Haikin
AUD | Comptroller/Controller/Auditor | 69 | 21-11-10 |
Gavin Doree
SAM | Sales & Marketing | 47 | 29-07-13 |
Susan Alpert
LAW | General Counsel | 78 | 01-01-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04-07-16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01-01-06 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16-04-15 |
Itai Arkin
BRD | Director/Board Member | 35 | 16-04-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 26 917 095 | 6 557 013 ( 24,36 %) | 0 | 24,36 % |
Bedrijfsgegevens
Meridian Bioscience Israel Ltd.
4 Ha'maayan Street
7177872, Modi'in-Maccabim-Re'ut
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+107,88% | 45,97 mln. | |
-2,89% | 185 mld. | |
-2,43% | 107 mld. | |
-4,10% | 67,55 mld. | |
+11,10% | 54,6 mld. | |
+15,86% | 47,42 mld. | |
+3,86% | 42,24 mld. | |
+9,55% | 28,24 mld. | |
+1,85% | 26,42 mld. | |
+12,40% | 25,66 mld. |
- Beurs
- Aandelen
- Koers EXEN
- Onderneming Exalenz Bioscience Ltd